Document is current
Any future updates will be listed below
-
Authors
Öcal, Osman
Schinner, Regina
Schütte, Kerstin
de Toni, Enrico N.
Loewe, Christian
van Delden, Otto
Vandecaveye, Vincent
Gebauer, Bernhard
Zech, Christoph J.
Sengel, Christian
Bargellini, Irene
Gasbarrini, Antonio
Sangro, Bruno
Pech, Maciej
Malfertheiner, Peter
Ricke, Jens
Seidensticker, Max
,
Kettner, E.
Amthauer, H.
Cwikla, J.
Walecki, J.
Klümpen, H.
Schott, E.
Kolligs, F.
Rosmorduc, O.
Menu, Y.
Leroy, V.
Mayerle, J.
Trumm, C.
Bartenstein, P.
Reiser, M.
Berg, T.
Moche, M.
Bilbao, I.
Gossner, L.
Reimer, P.
Popovic, P.
Stabuc, B.
Piasecki, P.
Podgajny, Z.
Sacco, R.
Peck-Radosavljevic, M.
Lammer, J.
Maleux, G.
Verslype, C.
Rosenberg, C.
Nitsche, D.
Waldenberger, P.
Vergniol, J.
Cassinotto, C.
Yalcin, S.
Peynircioglu, B.
Zavaglia, C.
Rampoldi, A.
Tran, A.
Chevallier, P.
Anty, R.
Trautwein, C.
Kuhl, C.
Grazioli, L.
Vogl, T.
Trojan, J.
Bartolozzi, C.
Iezzi, R.
Bronowicki, J. P.
Palmer, D.
Evans, J.
Sharma, R.
Weir, G.
Hubner, R.
Basu, B.
Ross, P.
-
Funding
Funding for this research was provided by:
bayer healthcare
sirtex
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 6 August 2021
Accepted: 5 December 2021
First Online: 4 January 2022
Declarations
:
: The study was approved by the local ethics committees. Study procedures were performed in accordance with the protocol and ethical principles that have their origin in the Declaration of Helsinki and the International Council for Harmonization-Good Clinical Practice. All patients provided written, informed consent to participate in the study. number, ; EudraCT 2009–012576-27.
: Not applicable.
: Kerstin Schuette: Personal fees: Bayer. Enrico de Toni: Personal fees: Bayer, during the conduct of the study. Personal fees: Ipsen, Eli Lilly & Co, Eisai, outside the submitted work. Bernhard Gebauer: Personal fees: Bayer, Sirtex. Christoph J Zech: Personal fees: Bayer. Irene Bargellini: Grants: Sirtex, during the conduct of the study. Personal fees: Bayer, Sirtex, Biocompatibles, Terumo, outside the submitted work. Bruno Sangro: Personal fees: Sirtex, BTG, Bayer, BMS, Astra Zeneca, Eli Lilly, Merck, Novartis, Terumo, Adaptimmune; Non-financial support: Sirtex, BMS, outside the submitted work. Maciej Pech: Grants: Sirtex, Bayer; Personal fees: Sirtex. Peter Malfertheiner: Grants: Bayer, Sirtex. Jens Ricke: Grants: Sirtex, Bayer; Personal fees: Sirtex, Bayer. Max Seidensticker: Personal fees: Bayer, Sirtex.
